ProQR CEO Daniel Anton de Boer buys 150,000 shares for $261,000
PRQR•CEO increases direct holding
- ProQR Therapeutics CEO Daniel Anton de Boer bought 150,000 ordinary shares at USD 1.74 each.
- His direct holding rose to 300,000 ordinary shares following the purchase.




